Lentigo Maligna

12 registered clinical trials studyying Lentigo Maligna.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs NCT06014619	Maastricht University Medical Center	—
Completed	Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors NCT06046144	Centre Hospitalier Universitaire de Saint Etienne	—
Terminated	Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage NCT04688749	Aristotle University Of Thessaloniki	—
Completed	Reflectance Confocal Microscopy to Diagnose MM & LM NCT03508297	Skin Care Network Ltd.	—
Completed	Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face NCT02723721	Centre Hospitalier Universitaire de Nice	Phase 2
Completed	Photodynamic Therapy for Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion as a Light Sensitizing Cream NCT02685592	Joint Authority for Päijät-Häme Social and Health Care	Phase 4
Completed	Radiotherapy or Imiquimod in Complex Lentigo Maligna NCT02394132	Melanoma and Skin Cancer Trials Limited	Phase 3
Withdrawn	Mohs and Immunofluorescence for Malignant Melanoma In Situ NCT02306512	University of Miami	N/A
Unknown	Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna NCT01088737	Medical University of Graz	Phase 2 / Phase 3
Completed	Effect of Topical Imiquimod on Lentigo Maligna NCT01161888	Jerry Marsden	Phase 4
Completed	In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis NCT00785369	Lucid, Inc.	N/A
Completed	Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna NCT00707174	University of Utah	N/A